FENNEC PHARMACEUTICALS INC. Repayments of Long-Term Debt
FENNEC PHARMACEUTICALS INC. (FENC) reported Repayments of Long-Term Debt of $19.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-03-27
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for the quarter ending 2022-12-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for the quarter ending 2014-09-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for the quarter ending 2014-06-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for the quarter ending 2014-03-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for fiscal 2025 was $19.48M, a 49.82% increase from fiscal 2024.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for fiscal 2024 was $13.00M.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for fiscal 2022 was $5.00M.
- FENNEC PHARMACEUTICALS INC. repayments of long-term debt for fiscal 2013 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 178 month | Repayments of Long-term Debt 181 month | Repayments of Long-term Debt 184 month | Repayments of Long-term Debt 187 month | Repayments of Long-term Debt 190 month | Repayments of Long-term Debt 193 month | Repayments of Long-term Debt 196 month | Repayments of Long-term Debt 199 month | Repayments of Long-term Debt 202 month | Repayments of Long-term Debt 205 month | Repayments of Long-term Debt 208 month | Repayments of Long-term Debt 211 month | Repayments of Long-term Debt 214 month | Repayments of Long-term Debt 217 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $19.48M 10-K · filed 2026-03-27 | |||||||||||||||||
| 2024-12-31 | $13.00M 10-K · filed 2026-03-27 | |||||||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $5.00M 10-K · filed 2024-03-29 | ||||||||||||||||
| 2022-09-30 | $5.00M 10-Q · filed 2023-11-09 | |||||||||||||||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $65.00K 10-Q · filed 2014-11-13 | |||||||||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $65.00K 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $65.00K 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $0.00 10-K · filed 2014-03-31 | $65.00K 10-K · filed 2014-03-31 | |||||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $65.00K 10-Q · filed 2013-11-18 | |||||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-08-11 | $65.00K 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $65.00K 10-Q · filed 2013-05-13 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $65.00K 10-K · filed 2013-04-01 | |||||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-18 | $0.00 derived: sum of 2 quarters · filed 2013-11-18 | $0.00 10-Q · filed 2013-11-18 | $0.00 derived: sum of 4 quarters · filed 2013-11-18 | $65.00K 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $0.00 derived: sum of 4 quarters · filed 2013-08-09 | $65.00K 10-Q · filed 2012-08-13 | |||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-13 | $0.00 derived: sum of 2 quarters · filed 2013-05-13 | $0.00 derived: sum of 3 quarters · filed 2013-05-13 | $0.00 derived: sum of 4 quarters · filed 2013-05-13 | $65.00K 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $0.00 derived: sum of 2 quarters · filed 2013-04-01 | $0.00 derived: sum of 3 quarters · filed 2013-04-01 | $0.00 10-K · filed 2013-04-01 | $65.00K 10-K · filed 2012-03-27 | |||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $65.00K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-13 | $0.00 10-Q · filed 2012-08-13 | $65.00K 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |